A biosensor is an integrated receptor-transducer device, which can convert a biological
response into an electrical signal. The design and development of biosensors have taken a …

As cut-outs from a graphene sheet, nanographenes (NGs) and graphene nanoribbons
(GNRs) are ideal cases with which to connect the world of molecules with that of bulk carbon …

Investigation of metal–organic frameworks (MOFs) for biomedical applications has attracted
much attention in recent years. MOFs are regarded as a promising class of nanocarriers for …

Since the first dendrimer was reported in 1978 by Fritz Vögtle, dendrimer research has
grown exponentially, from synthesis to application in the past four decades. The distinct …

Worldwide nanotechnology development and application have fueled many scientific
advances, but technophilic expectations and technophobic demands must be …

Biomedicine represents one of the main study areas for dendrimers, which have proven to
be valuable both in diagnostics and therapy, due to their capacity for improving solubility …

The application of nanomedicines is increasing rapidly with the promise of targeted and
efficient drug delivery. Nanomedicines address the shortcomings of conventional therapy, as …

Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …

The cosmetic industry is dynamic and ever-evolving. Especially with the introduction and
incorporation of nanotechnology-based approaches into cosmetics for evincing novel …

Nonspecific distribution and uncontrollable release of drugs in conventional drug delivery
systems (CDDSs) have led to the development of smart nanocarrier-based drug delivery …